Trial intelligence / Profile preview

Total Toothpaste for Gingivitis Inflammation

NCT00941668Phase 4Completed

Sponsor
Colgate-Palmolive
Start
Jan 2007
Primary completion
Aug 2008
Modality
Recombinant Proteins and Enzymes, Cell Therapies
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of red blood cells in gingivitis (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: Interleukin-1 at 4 weeks and Interleukin-6 at 4 weeks. Started Jan 2007; status: completed.

02

Drugs

red blood cells
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT00941668.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00941668.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call